Percutaneous endoscopic gastrostomy: a long-term follow-up
| Autor: | Arnaldo Ferrari, Luca Todros, Antonio Vuolo, Giuseppe M. Rovera, Rosalba Galletti, Concetta Finocchiaro, Franco Balzola |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors Adolescent Endocrinology Diabetes and Metabolism medicine.medical_treatment Aspiration pneumonia Pneumonia Aspiration Enteral administration Enteral Nutrition Postoperative Complications Percutaneous endoscopic gastrostomy Gastroscopy medicine Humans Subcutaneous abscess Survival rate Aged Aged 80 and over Gastrostomy Nutrition and Dietetics business.industry Syndrome Middle Aged medicine.disease Abscess Surgery Survival Rate Parenteral nutrition Erythema Head and Neck Neoplasms Equipment Failure Female Complication business Follow-Up Studies |
| Zdroj: | Nutrition (Burbank, Los Angeles County, Calif.). 13(6) |
| ISSN: | 0899-9007 |
| Popis: | Percutaneous endoscopic gastrostomy (PEG) is the preferred method of long-term tube feeding, but only a few studies describe a long-term follow-up. The purpose of this study is to analyze the follow-up of PEG enteral feeding patients in the long term, and to report on the complication and survival rates. Between January 1991 and June 1995, we studied 136 patients (49% cancer and 51% non-cancer patients; male = 68%, female = 32%) after PEG insertion. One hundred twenty-eight patients had a long-term follow-up of over 31 d. The mean duration of PEG feeding was 277 ± 358 d (range 31–1590): 17% of patients returned to oral feeding, 34% continued enteral nutrition, and 49% died. Major complications occurred in 3% of the patients: 1 aspiration pneumonia, 1 subcutaneous abscess, 2 buried bumper syndrome. Minor complications arose in 14% of our cases: 8 tube blockages, 4 tube dislodgements, 6 site infections. For the whole group of 136 patients, survival probabilities after PEG insertion at 1, 6, 12, and 24 mo were 90.5%, 52%, 42%, and 35%, respectively. After 180 d, the difference in survival probabilities between cancer and non-cancer patients became significant (P < 0.02). Median survival probability was 64% for non-cancer and 39% for cancer patients, and this trend did not change over 2 y. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect